Cargando…

Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman

OBJECTIVES: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use o...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Philomena C., Kumar, Shiyam, Kakaria, Annupam, Al-Sukaiti, Rashid, Al-Baimani, Khalid, Hamid, Rana S., Mittal, Alok K., Al-Balushi, Muna, Burney, Ikram A., Al-Moundhri, Mansour S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968907/
https://www.ncbi.nlm.nih.gov/pubmed/33777430
http://dx.doi.org/10.18295/squmj.2021.21.01.014
_version_ 1783666138972946432
author D’Souza, Philomena C.
Kumar, Shiyam
Kakaria, Annupam
Al-Sukaiti, Rashid
Al-Baimani, Khalid
Hamid, Rana S.
Mittal, Alok K.
Al-Balushi, Muna
Burney, Ikram A.
Al-Moundhri, Mansour S.
author_facet D’Souza, Philomena C.
Kumar, Shiyam
Kakaria, Annupam
Al-Sukaiti, Rashid
Al-Baimani, Khalid
Hamid, Rana S.
Mittal, Alok K.
Al-Balushi, Muna
Burney, Ikram A.
Al-Moundhri, Mansour S.
author_sort D’Souza, Philomena C.
collection PubMed
description OBJECTIVES: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the researchers’ experiences. METHODS: This retrospective follow-up study included patients who had received cancer treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the port-a-cath were recorded. RESULTS: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05). On multivariate analysis, however, none of the factors was found to be significant. CONCLUSION: Infection was the most common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’ previous experience and compares favorably with several published reports.
format Online
Article
Text
id pubmed-7968907
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-79689072021-03-26 Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman D’Souza, Philomena C. Kumar, Shiyam Kakaria, Annupam Al-Sukaiti, Rashid Al-Baimani, Khalid Hamid, Rana S. Mittal, Alok K. Al-Balushi, Muna Burney, Ikram A. Al-Moundhri, Mansour S. Sultan Qaboos Univ Med J Clinical & Basic Research OBJECTIVES: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the researchers’ experiences. METHODS: This retrospective follow-up study included patients who had received cancer treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the port-a-cath were recorded. RESULTS: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05). On multivariate analysis, however, none of the factors was found to be significant. CONCLUSION: Infection was the most common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’ previous experience and compares favorably with several published reports. Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2021-02 2021-03-15 /pmc/articles/PMC7968907/ /pubmed/33777430 http://dx.doi.org/10.18295/squmj.2021.21.01.014 Text en © Copyright 2021, Sultan Qaboos University Medical Journal, All Rights Reserved This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nd/4.0/) .
spellingShingle Clinical & Basic Research
D’Souza, Philomena C.
Kumar, Shiyam
Kakaria, Annupam
Al-Sukaiti, Rashid
Al-Baimani, Khalid
Hamid, Rana S.
Mittal, Alok K.
Al-Balushi, Muna
Burney, Ikram A.
Al-Moundhri, Mansour S.
Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
title Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
title_full Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
title_fullStr Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
title_full_unstemmed Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
title_short Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
title_sort complications and management of totally implantable central venous access ports in cancer patients at a university hospital in oman
topic Clinical & Basic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968907/
https://www.ncbi.nlm.nih.gov/pubmed/33777430
http://dx.doi.org/10.18295/squmj.2021.21.01.014
work_keys_str_mv AT dsouzaphilomenac complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT kumarshiyam complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT kakariaannupam complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT alsukaitirashid complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT albaimanikhalid complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT hamidranas complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT mittalalokk complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT albalushimuna complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT burneyikrama complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman
AT almoundhrimansours complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman